Antitumor and apoptotic effects of bergaptol are mediated via mitochondrial death pathway and cell cycle arrest in human breast carcinoma cells

Authors

  • Zhi-Cheng Ge Department of General Surgery, Beijing Friendship Hospital, Capital University of Medical Science, Beijing 100050
  • Xiang Qu Department of General Surgery, Beijing Friendship Hospital, Capital University of Medical Science, Beijing 100050
  • He-Fen Yu Department of Biochemistry and Molecular Biology, School of Basic Medicine, Capital Medical University; Cancer Institute of Capital Medical University; Beijing Key Laboratory for Cancer Invasion and Metastasis Research. Beijing 100069
  • Hui-Ming Zhang Department of General Surgery, Beijing Friendship Hospital, Capital University of Medical Science, Beijing 100050
  • Zi-Han Wang Department of General Surgery, Beijing Friendship Hospital, Capital University of Medical Science, Beijing 100050
  • Zhong-Tao Zhang Department of General Surgery, Beijing Friendship Hospital, Capital University of Medical Science, Beijing 100050 http://orcid.org/0000-0002-0758-6476

DOI:

https://doi.org/10.3329/bjp.v11i2.24644

Keywords:

Antitumor, Apoptosis, Bergaptol, Cell cycle arrest, Human breast carcinoma cell, Mitochondria

Abstract

The aim of the present research work was to investigate the anti-cancer and apoptotic effects of bergaptol in human breast cancer cells (MCF-7). The effects on cell cycle arrest and caspase activation were evaluated. MTT assay was used to evaluate the effect of the compound on cell viability. Cellular morphology was demonstrated by fluorescence microscopy. Flow cytometry was used to analyze effect of bergaptol on cell cycle and apoptosis. The results revealed that bergaptol induced dose-dependent cytotoxic effect on MCF-7 cell viability showing IC50 value of 52.2 µM. Bergaptol induced both early and late apoptosis in concentration-dependent manner. After treatment with bergaptol, an increase in the proportion of cells in the S-phase (37.2, 45.3 and 65.1% as compared to 28.6% in untreated cells) and a reduction in the fraction of cells in the G1 phase (44.1, 41.6 and 35.2% as compared to 51.2% in the untreated cells) was observed.

Downloads

Download data is not yet available.
Abstract
1360
Download
847 Read
760

References

Böhm I. Disruption of the cytoskeleton after apoptosis induction by autoantibodies. Autoimmunity 2003; 36: 18389.

Conforti F, Menichini F. Phenolic compounds from plants as nitric oxide production inhibitors. Curr Med Chem. 2011; 18: 1137-45.

Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, Blaydes JP, Brennan K, Brown NJ, Bryant HE, Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer, Breast Cancer Res. 2013; 15: R92.

Elmore S. Apoptosis: A review of programmed cell death. Toxicol Pathol. 2007; 35: 495-516.

Guzman-Villanueva D, El-Sherbiny IM, Herrera-Ruiz D, Smyth HD. Design and in vitro evaluation of a new nano-microparticulate system for enhanced aqueous-phase solubility of curcumin. Biomed Res Int. 2013; 2013: 724763.

Jemal, A, Bray F, Center MM, Felay J, Ward E, Forman D. Global cancer statistics. CA-Cancer J Clin. 2011; 61: 6990.

Khoo BY, Chua SL, Balaram P. Apoptotic effects of chrysin in human cancer cell lines. Int J Mol Sci. 2010; 11: 218899.

Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 2005; 4: 206-20.

Ma L, Wen ZS, Liu Z, Hu Z, Ma J, Chen XQ, Liu YQ, Pu JX, Xiao WL, Sun HD, Zhou GB. Overexpression and small molecule-triggered down regulation of CIP2A in lung cancer. PLoS One. 2011; 6: e20159.

Molinari G. Natural products in drug discovery: Present status and perspectives. Adv Exp Med Biol. 2009; 655: 13-27.

Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007; 70: 46177.

Ponci V, Figueiredo CR, Massaoka MH, de Farias CF, Matsuo AL, Sartorelli P, Lago JH. Neolignans from Nectandra megapotamica (Lauraceae) display in vitro cytotoxic activity and induce apoptosis in leukemia cells. Molecules 2015; 20: 2757-68.

Stanley WL, Vannier SH. Chemical composition of lemon oil. I. Isolation of a series of substituted coumarins. J Am Chem Soc. 1957; 79: 348891.

Susin SA, Daugas E, Ravagnan L, Samejima K, Zamzami N, Loeffler M, Costantini P, Ferri KF, Irinopoulou T, Prévost MC, Brothers G, Mak TW, Penninger J, Earnshaw WC, Kroemer G. Two distinct pathways leading to nuclear apoptosis. J Exp Med. 2000; 192: 57180.

Downloads

Additional Files

Published

2016-04-17

How to Cite

Ge, Z.-C., X. Qu, H.-F. Yu, H.-M. Zhang, Z.-H. Wang, and Z.-T. Zhang. “Antitumor and Apoptotic Effects of Bergaptol Are Mediated via Mitochondrial Death Pathway and Cell Cycle Arrest in Human Breast Carcinoma Cells”. Bangladesh Journal of Pharmacology, vol. 11, no. 2, Apr. 2016, pp. 489-94, doi:10.3329/bjp.v11i2.24644.

Issue

Vol. 11 No. 2 (2016)

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).